Related Experiment Video
Updated: Aug 10, 2026

07:33
A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
Published on: May 21, 2010
Cerebellar synaptic defects and abnormal motor behavior in mice lacking alpha- and beta-dystrobrevin
R Mark Grady1, David F Wozniak, Kevin K Ohlemiller
1Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110, USA. grady@kids.wustl.edu
Summary
The dystrophin-glycoprotein complex (DGC), including dystrobrevins (DBs), is crucial for inhibitory synapses in the cerebellum. Loss of DGC disrupts synaptic function and sensorimotor behavior, suggesting central nervous system involvement in muscular dystrophy.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Dystrobrevins (alphaDB and betaDB) bind dystrophin, forming part of the dystrophin-glycoprotein complex (DGC).
- The DGC links the cytoskeleton to extracellular proteins, playing roles in various tissues.
Purpose of the Study:
- To investigate the role of dystrobrevins and dystrophin in cerebellar inhibitory synapses.
- To determine the impact of DGC disruption on synaptic function and behavior.
Main Methods:
- Immunohistochemical analysis of Purkinje cells in wild-type and mutant mice.
- Assessment of GABA receptor clusters and sensorimotor behaviors.
Main Results:
- AlphaDB, betaDB, and dystrophin colocalize at specific inhibitory synapses on Purkinje cells.
- Absence of DBs or dystrophin leads to depleted DGC components at these synapses.
- Mutations in DGC components decrease GABA receptor cluster size/number and impair cerebellar sensorimotor function.
- Synaptic and behavioral deficits are most pronounced in double mutants lacking both alphaDB and betaDB.
Conclusions:
- The DGC is essential for the maturation and function of specific cerebellar inhibitory synapses.
- Dystrobrevins are key components of the DGC at these synapses.
- Disruption of the DGC causes synaptic and behavioral abnormalities, potentially contributing to CNS defects in muscular dystrophy.

